Research & Development

kk4444在线观看经典AV三级在线亚洲成人视频快讯:五谷磨房高开近35% 百事投10.2亿港元成二股东

發布時間︰

次竟然會覺得這個頭發灰白,嘴巴的線條生硬,失明的眼楮神色嚴峻的女人 長得丑陋不堪。現在她的臉上閃耀著愛和同情的光輝。我覺得,仿佛這雙永 遠只反射出一片黑暗的眼楮對人生現實的了解甚于那些清澈明亮地觀看世界 的眼楮。 kk4444在线观看 “是的。” “肯定就這幾個。” “是,上校先生!”经典AV三级在线 “可是奇恥大辱啊!”現在施泰因許貝插進來了,“偏偏是這個放高利 亚洲成人视频

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo